History
  • No items yet
midpage
GlaxoSmithKline LLC v. Brooks
8:22-cv-00364
| D. Maryland | Feb 15, 2022
Read the full case

Background

  • GSK, a pharmaceutical manufacturer, alleges it maintains confidential manufacturing processes, SOPs, training materials, and a proprietary Quality Management System as trade secrets.
  • Denise Brooks was a GSK Quality Systems Lead from 2006 until her resignation on January 13, 2022, with access to those materials.
  • GSK alleges Brooks arranged to swap laptops with IT on the eve of her resignation; IT uploaded her OneDrive to the new laptop (ZBook), creating local copies, and Brooks left the facility with the ZBook and her badge.
  • GSK further alleges Brooks emailed GSK documents to a personal account and copied files to external drives around her resignation; a forensic consultant supports these concerns.
  • GSK repeatedly demanded return of property and cooperation; Brooks retained counsel and did not substantively engage; GSK filed for a TRO seeking return/preservation of devices/data and a limited third‑party inspection.
  • The court granted GSK's TRO request pending further proceedings and set scheduling/hearing dates.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether GSK is likely to succeed on DTSA/MUTSA misappropriation claims Brooks had authorized access but acquired copies of trade secrets by improper means (removing laptop/files, emailing to personal account) and breached confidentiality and return policies Brooks disputed facts (implicitly) and did not substantively engage; no developed defense in the record Court: GSK likely to succeed; allegations and supporting declarations show improper acquisition and possession of trade secrets
Whether GSK will suffer irreparable harm without preliminary relief Loss of trade secrets is irreversible and could cause unquantifiable, permanent business injury if disclosed to competitors Any monetary damages would be speculative; Brooks offered no effective rebuttal Court: Irreparable harm likely; trade‑secret loss justifies TRO
Whether the TRO is in the public interest Protecting trade secrets and preventing unfair business practices serves the public interest No public interest against protecting confidential manufacturing and safety‑related processes Court: Public interest favors granting the TRO
Whether the requested remedial measures (return, preservation, limited third‑party inspection) unreasonably burden Brooks’ privacy GSK needs to verify removal of misappropriated data; inspection limited to devices used to copy GSK material Third‑party inspection implicates privacy; burden on Brooks Court: Balance favors GSK; limited scope of inspection is appropriate and does not outweigh GSK’s interest

Key Cases Cited

  • In re Microsoft Corp. Antitrust Litig., 333 F.3d 517 (4th Cir. 2003) (describing TRO/preliminary injunction purpose to preserve the status quo)
  • Winter v. Natural Res. Defense Council, Inc., 555 U.S. 7 (2008) (plaintiff must show likelihood of success, irreparable harm, balance of equities, and public interest)
  • Real Truth About Obama, Inc. v. Fed. Election Comm'n, 575 F.3d 342 (4th Cir. 2009) (Fourth Circuit requires each Winter factor be satisfied independently)
  • Dewhurst v. Century Aluminum Co., 649 F.3d 287 (4th Cir. 2011) (applying Winter factors in preliminary‑injunction context)
  • Brightview Grp., LP v. Teeters, 441 F. Supp. 3d 115 (D. Md. 2020) (trade‑secret protection supports injunctive relief; public interest favors protection)
  • Sys. 4, Inc. v. Landis & Gyr, Inc., [citation="8 F. App'x 196"] (4th Cir. 2001) (misappropriation may be established by acquisition through improper means without showing use)
  • Direx Israel, Ltd. v. Breakthrough Med. Corp., 952 F.2d 802 (4th Cir. 1991) (irreparable harm requires injury that is certain, great, actual, and not remediable by money damages)
  • Weinberger v. Romero‑Barcelo, 456 U.S. 305 (1982) (courts must consider public consequences when granting extraordinary injunctive relief)
  • Blackwelder Furniture Co. v. Seilig Mfg. Co., 550 F.2d 189 (4th Cir. 1977) (prior Fourth Circuit framework for balancing hardship before Real Truth; discussed in context of standards)
  • Continental Group Inc. v. Amoco Chems. Corp., 614 F.2d 351 (3d Cir. 1980) (balancing harms to parties and interested persons when evaluating injunctions)
  • Delaware River Port Auth. v. Transamerican Trailer Transp., Inc., 501 F.2d 917 (3d Cir. 1974) (considerations for equitable balancing in injunctive relief)
Read the full case

Case Details

Case Name: GlaxoSmithKline LLC v. Brooks
Court Name: District Court, D. Maryland
Date Published: Feb 15, 2022
Docket Number: 8:22-cv-00364
Court Abbreviation: D. Maryland